{"id":6601,"date":"2020-11-20T10:29:36","date_gmt":"2020-11-20T09:29:36","guid":{"rendered":"https:\/\/forum.schreiner-group.com\/?p=6601"},"modified":"2026-04-01T09:34:04","modified_gmt":"2026-04-01T07:34:04","slug":"future-healthcare-digitalization-of-health","status":"publish","type":"post","link":"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/","title":{"rendered":"Future Healthcare: Digitalization of Health"},"content":{"rendered":"<section class=\"wpb-content-wrapper\"><p>[vc_row full_width=&#8221;stretch_row_content_no_spaces&#8221; content_placement=&#8221;top&#8221; css=&#8221;.vc_custom_1611911316198{margin-top: 150px !important;}&#8221; parallax_background_image=&#8221;7080&#8243;][vc_column][vc_empty_space height=&#8221;615px&#8221;][\/vc_column][\/vc_row][vc_row css=&#8221;.vc_custom_1594636600423{background-color: #ffffff !important;}&#8221; el_class=&#8221;article_bighead&#8221;][vc_column][vc_custom_heading text=&#8221;SCHREINER MEDIPHARM&#8221; font_container=&#8221;tag:h2|text_align:center&#8221; use_theme_fonts=&#8221;yes&#8221; el_class=&#8221;topcategory&#8221;][vc_custom_heading text=&#8221;Future Healthcare:<br \/>\nDigitalization of Health&#8221; font_container=&#8221;tag:h1|text_align:center&#8221; use_theme_fonts=&#8221;yes&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<strong>Schreiner Group\u2019s first contact with a pharmaceutical corporation took place in 1988. It resulted in the development of Pharma-Tac, a hanger label for infusion bottles and a world first. From then on, the company specialized in solutions for the pharmaceutical industry\u2014and established a unit dedicated to this sector. Today, Schreiner MediPharm is an internationally successful business unit and a leading developer and manufacturer of specialty labels and marking solutions for pharmaceutical manufacturers and medical device technology providers. The business unit now aims to increasingly address the entire healthcare industry. Schreiner MediPharm\u2019s President Dr. Thomas Schweizer discusses the resulting effects and what the future in healthcare looks like.<\/strong>[\/vc_column_text][vc_row_inner][vc_column_inner][vc_empty_space height=&#8221;25px&#8221;][vc_column_text]<strong>What was your goal when you started your job as President of Schreiner MediPharm?<\/strong><\/p>\n<p><em><strong>Thomas Schweizer:<\/strong> Schreiner MediPharm has a continuous track record of launching new technologies and products of importance to the pharmaceutical industry: Pharma-Tac labels with integrated hangers, Pharma-Comb labels with detachable parts, Needle-Trap as an innovative needle protection solution, Pharma-Labels with integrated analog and digital security features, RFID solutions, specialty tamper-evident solutions for syringes and vials, and much more. In conversations with customers, I regularly receive feedback that Schreiner MediPharm successfully responds to challenges with smart solutions. I took on my role with the goal of continuing this success story\u2014and we\u2019ve got a wealth of ideas in the pipeline to achieve this.<\/em>[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text]<strong>So far, you\u2019ve focused on the pharmaceutical industry and medical device technology. Now, you\u2019ve defined healthcare as a market, going forward. What has motivated you to do so? What will change?<\/strong><\/p>\n<p><em>Over the past years, we\u2019ve increasingly been receiving customer inquiries going beyond purely functional labels. These are challenges we intend to meet. As a result, we\u2019ve had more intensive interactions with other players in the healthcare sector such as software and system providers, logistics companies, firms in the field of diagnostics through to hospital operators. So, we\u2019re changing to the extent that we\u2019re expanding our portfolio of solutions. Such changes, however, are driven by the demands of our customers. Of course, this does not imply any changes in how we work together with customers in our current business relationships.<\/em>[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][\/vc_column_inner][vc_column_inner width=&#8221;1\/3&#8243;][vc_empty_space height=&#8221;18px&#8221;][vc_single_image image=&#8221;6559&#8243; img_size=&#8221;full&#8221; add_caption=&#8221;yes&#8221; onclick=&#8221;link_image&#8221; css_animation=&#8221;fadeIn&#8221;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text]<strong>That sounds promising. Was this move necessary due to an emerging trend in customer requirements?<\/strong><\/p>\n<p><em>There\u2019s a growing demand for interactive labels, specifically, RFID-Labels that communicate with the user and require a corresponding software connection. In such projects, we collaborate with specialized companies providing systems and solutions for logistics, identification, track &amp; trace and automation. We\u2019re seeing a trend and demand here, particularly among hospitals that would like to centrally, and especially digitally, control their medications and consumables in the future.<\/em>[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][\/vc_column_inner][vc_column_inner width=&#8221;1\/3&#8243;][vc_empty_space height=&#8221;18px&#8221;][vc_single_image image=&#8221;14648&#8243; img_size=&#8221;large&#8221; onclick=&#8221;link_image&#8221;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text]<strong>You\u2019re referring to digitalization in the healthcare sector? How is Schreiner MediPharm planning to meet the demands of this fast-growing market?<\/strong><\/p>\n<p><em>The digital healthcare market pursues the objective of implementing processes and applications in more reliable, faster and cost-effective ways. We\u2019re already very well positioned with our current solutions, but are planning to extend our existing expertise and capital expenditures. For instance, we\u2019ve increasingly invested in RFID technology in recent years. One of our latest developments is the \u201cRobust RFID-Label.\u201d It was created because our discussion partners demanded that our RFID solutions provide mechanical and electrical protection against failures. For users in the healthcare sector, this is absolutely critical, because any failure of an RFID chip may lead to problems and delays in the process and ultimately jeopardize patient safety. In parallel with this product development, we\u2019ve been building up expertise that targets a total solution and are working together with software producers, system providers, logistics companies and packaging machine manufacturers.<\/em>[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][\/vc_column_inner][vc_column_inner width=&#8221;1\/3&#8243;][vc_empty_space height=&#8221;18px&#8221;][vc_single_image image=&#8221;6563&#8243; img_size=&#8221;large&#8221; onclick=&#8221;link_image&#8221;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text]<strong>Going forward, does this mean that you\u2019re going to put greater emphasis on collaborative projects and partnerships in the area of RFID?<\/strong><\/p>\n<p><em>Not just in this area. We also see a need to act together with various partners in networks in the areas of security features, needle protection solutions and drug protection. Here, for instance, we\u2019ve already been working together with renowned manufacturers in the development of label solutions for UV and light protection, for diffusion barriers and for cryogenic temperature applications.<\/em>[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][\/vc_column_inner][vc_column_inner width=&#8221;1\/3&#8243;][vc_empty_space height=&#8221;18px&#8221;][vc_single_image image=&#8221;15303&#8243; img_size=&#8221;large&#8221; onclick=&#8221;link_image&#8221;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text]<strong>You mentioned security features. Are you seeing increasing requirements in this area from the market\u2019s perspective?<\/strong><\/p>\n<p><em>Yes, and these requirements are significant. We\u2019ve been developing and producing security labels for authentication and tamper evidence for primary and secondary packaging for more than 25 years. There\u2019s an increasing demand for new security functions, especially for new drugs. These requirements have, not least, partially been driven by the Falsified Medicines Directive that was introduced Europe-wide in 2019 in order to stop illegal trading of counterfeit medicines. We\u2019ve continuously extended our portfolio of sealing solutions as well as of overt, covert and digital security features in recent years.<\/em>[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][\/vc_column_inner][vc_column_inner width=&#8221;1\/3&#8243;][vc_empty_space height=&#8221;18px&#8221;][vc_single_image image=&#8221;14119&#8243; img_size=&#8221;large&#8221; onclick=&#8221;link_image&#8221;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<strong>Schreiner MediPharm\u2019s key markets are the EU, the USA and China. Going forward, will they continue to be or are you planning to develop markets in other countries?<\/strong><\/p>\n<p><em>We produce in these regions, but deliver our products to more than 70 countries, in some of which we have sales offices. As a result, we can ensure direct, fast communication and local support. In some cases, though, we\u2019re already working together with partners there as well. On the whole, working and interacting with partners is becoming increasingly important for us, not only in terms of distribution.<\/em>[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text]<strong>What technologies is Schreiner MediPharm planning to emphasize in the coming years?<\/strong><\/p>\n<p><em>Integrated electronics is a technology that opens up a range of new opportunities for diverse applications. With \u201cElectronics in Films\u201d (EiF), we\u2019re able to achieve sensor solutions that can be used for medication therapy monitoring. Medication adherence monitoring is particularly helpful in clinical trials and in self-medication\u2014for instance, by enabling chief investigators to determine which medication was taken at what time or by supporting patients in taking their medications. An additional option, for instance, is temperature monitoring, which is important for temperature-sensitive substances such as biopharmaceuticals.<\/em>[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][\/vc_column_inner][vc_column_inner width=&#8221;1\/3&#8243;][vc_empty_space height=&#8221;18px&#8221;][vc_single_image image=&#8221;6569&#8243; img_size=&#8221;large&#8221; onclick=&#8221;link_image&#8221;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<strong>Looking at the healthcare sector as a whole: what areas is Schreiner MediPharm going to focus on, going forward?<\/strong><\/p>\n<p><em>Clearly, our focus for the next years will remain on the pharmaceutical sector and medical device technology. What will change, though, is that we\u2019re also going to get in touch with companies from totally different sectors for some projects. This will enable us to develop additional fields in healthcare and offer our customers holistic and all-new solutions from a one-stop shop.<\/em>[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<strong>Considering the wealth of ideas and innovations: which product has thrilled you from day one and still does?<\/strong><\/p>\n<p><em>Well, this is probably the most difficult question you\u2019ve asked me. I\u2019m thrilled by all of our existing products featuring a wide variety of functionalities and quality aspects. Be it RFID-Labels, security features for product and brand protection, drug protection solutions or integrated electronics, we add decisive value for our customers and their customers with all our products and solutions. However, if I\u2019d have to pick out a specific product, I\u2019d say that I\u2019m always especially excited about meetings focused on Robust RFID\u2014which may in part be due to the previous stations in my professional career.<\/em>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=&#8221;25px&#8221;][\/vc_column][\/vc_row][vc_row el_class=&#8221;kastenunten&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_column_text el_class=&#8221;kastenunten&#8221; css=&#8221;.vc_custom_1774969494935{background-color: #e1e7f5 !important;}&#8221;]<strong>Dr. Thomas Schweizer<\/strong> has been President of Schreiner MediPharm since January 2019. The native of Freiburg im Breisgau with a PhD in physics held managerial functions at Infineon Technologies AG in Munich before founding Aipermon GmbH &amp; Co. KG, a medical device technology firm. Afterwards, Dr. Schweizer worked as Head of Business Unit Medical Applications at Berliner Glas Group.[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;6551&#8243; img_size=&#8221;full&#8221; add_caption=&#8221;yes&#8221; onclick=&#8221;link_image&#8221; css_animation=&#8221;fadeIn&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=&#8221;25px&#8221;][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>Schreiner Group\u2019s first contact with a pharmaceutical corporation took place in 1988. It resulted in the development of Pharma-Tac, a hanger label for infusion bottles and a world first. From then on, the company specialized in solutions for the pharmaceutical industry\u2014and established a unit dedicated to this sector. Today, Schreiner MediPharm is an internationally successful business unit and a leading developer and manufacturer of specialty labels and marking solutions for pharmaceutical manufacturers and medical device technology providers. The business unit now aims to increasingly address the entire healthcare industry. Schreiner MediPharm\u2019s President Dr. Thomas Schweizer discusses the resulting effects and what the future in healthcare looks like.<\/p>\n","protected":false},"author":2,"featured_media":7078,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[187],"tags":[216,199,223,203,213],"class_list":["post-6601","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-schreiner-medipharm-en","tag-authentication","tag-drug-protection-en","tag-medication-adherence-monitoring-en","tag-rfid-nfc-en","tag-tamper-evidence"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Future Healthcare: Digitalization of Health - Schreiner Group Forum<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Future Healthcare: Digitalization of Health - Schreiner Group Forum\" \/>\n<meta property=\"og:description\" content=\"Schreiner Group\u2019s first contact with a pharmaceutical corporation took place in 1988. It resulted in the development of Pharma-Tac, a hanger label for infusion bottles and a world first. From then on, the company specialized in solutions for the pharmaceutical industry\u2014and established a unit dedicated to this sector. Today, Schreiner MediPharm is an internationally successful business unit and a leading developer and manufacturer of specialty labels and marking solutions for pharmaceutical manufacturers and medical device technology providers. The business unit now aims to increasingly address the entire healthcare industry. Schreiner MediPharm\u2019s President Dr. Thomas Schweizer discusses the resulting effects and what the future in healthcare looks like.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Schreiner Group Forum\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-20T09:29:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-01T07:34:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/01\/Future_Healthcare.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"markus.liedl@schreiner-group.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"markus.liedl@schreiner-group.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/\",\"url\":\"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/\",\"name\":\"Future Healthcare: Digitalization of Health - Schreiner Group Forum\",\"isPartOf\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/01\/Future_Healthcare.jpg\",\"datePublished\":\"2020-11-20T09:29:36+00:00\",\"dateModified\":\"2026-04-01T07:34:04+00:00\",\"author\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc\"},\"breadcrumb\":{\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/#primaryimage\",\"url\":\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/01\/Future_Healthcare.jpg\",\"contentUrl\":\"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/01\/Future_Healthcare.jpg\",\"width\":1280,\"height\":853},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/forum.schreiner-group.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Future Healthcare: Digitalization of Health\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#website\",\"url\":\"https:\/\/forum.schreiner-group.com\/de\/\",\"name\":\"Schreiner Group Forum\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/forum.schreiner-group.com\/de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc\",\"name\":\"markus.liedl@schreiner-group.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g\",\"caption\":\"markus.liedl@schreiner-group.com\"},\"url\":\"https:\/\/forum.schreiner-group.com\/en\/author\/markus-liedlschreiner-group-de\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Future Healthcare: Digitalization of Health - Schreiner Group Forum","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/","og_locale":"en_US","og_type":"article","og_title":"Future Healthcare: Digitalization of Health - Schreiner Group Forum","og_description":"Schreiner Group\u2019s first contact with a pharmaceutical corporation took place in 1988. It resulted in the development of Pharma-Tac, a hanger label for infusion bottles and a world first. From then on, the company specialized in solutions for the pharmaceutical industry\u2014and established a unit dedicated to this sector. Today, Schreiner MediPharm is an internationally successful business unit and a leading developer and manufacturer of specialty labels and marking solutions for pharmaceutical manufacturers and medical device technology providers. The business unit now aims to increasingly address the entire healthcare industry. Schreiner MediPharm\u2019s President Dr. Thomas Schweizer discusses the resulting effects and what the future in healthcare looks like.","og_url":"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/","og_site_name":"Schreiner Group Forum","article_published_time":"2020-11-20T09:29:36+00:00","article_modified_time":"2026-04-01T07:34:04+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/01\/Future_Healthcare.jpg","type":"image\/jpeg"}],"author":"markus.liedl@schreiner-group.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"markus.liedl@schreiner-group.com","Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/","url":"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/","name":"Future Healthcare: Digitalization of Health - Schreiner Group Forum","isPartOf":{"@id":"https:\/\/forum.schreiner-group.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/#primaryimage"},"image":{"@id":"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/#primaryimage"},"thumbnailUrl":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/01\/Future_Healthcare.jpg","datePublished":"2020-11-20T09:29:36+00:00","dateModified":"2026-04-01T07:34:04+00:00","author":{"@id":"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc"},"breadcrumb":{"@id":"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/#primaryimage","url":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/01\/Future_Healthcare.jpg","contentUrl":"https:\/\/forum.schreiner-group.com\/wp-content\/uploads\/2021\/01\/Future_Healthcare.jpg","width":1280,"height":853},{"@type":"BreadcrumbList","@id":"https:\/\/forum.schreiner-group.com\/en\/future-healthcare-digitalization-of-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/forum.schreiner-group.com\/en\/"},{"@type":"ListItem","position":2,"name":"Future Healthcare: Digitalization of Health"}]},{"@type":"WebSite","@id":"https:\/\/forum.schreiner-group.com\/de\/#website","url":"https:\/\/forum.schreiner-group.com\/de\/","name":"Schreiner Group Forum","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/forum.schreiner-group.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/bd0e2515cfe9118ea30379405cb6f7dc","name":"markus.liedl@schreiner-group.com","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/forum.schreiner-group.com\/de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e83202ed81ba95ae0113c3f2d897918a?s=96&d=mm&r=g","caption":"markus.liedl@schreiner-group.com"},"url":"https:\/\/forum.schreiner-group.com\/en\/author\/markus-liedlschreiner-group-de\/"}]}},"_links":{"self":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts\/6601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/comments?post=6601"}],"version-history":[{"count":8,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts\/6601\/revisions"}],"predecessor-version":[{"id":15308,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/posts\/6601\/revisions\/15308"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/media\/7078"}],"wp:attachment":[{"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/media?parent=6601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/categories?post=6601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forum.schreiner-group.com\/en\/wp-json\/wp\/v2\/tags?post=6601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}